Recent insider trading activity from Boyd Taylor, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Avalo Therapeutics, Inc. | $AVTX | Boyd Taylor | Chief Business Officer | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 18,133,968 | 9999.99% | 0.52% |
| Oct. 1, 2025 | Avalo Therapeutics, Inc. | $AVTX | Boyd Taylor | Chief Business Officer | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 10,671,934 | 9999.99% | 2.58% |